Bolt Biotherapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs.

CEO

William P. Quinn

CEOWilliam P. Quinn

Employees

Employees52

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2015

Founded2015

Employees

Employees52

BOLT Key Statistics

Market cap

10.60M

Market cap10.60M

Price-Earnings ratio

-0.17

Price-Earnings ratio-0.17

Dividend yield

—

Dividend yield—

Average volume

22.08K

Average volume22.08K

High today

$5.79

High today$5.79

Low today

$5.53

Low today$5.53

Open price

$5.74

Open price$5.74

Volume

21.50K

Volume21.50K

52 Week high

$15.60

52 Week high$15.60

52 Week low

$5.20

52 Week low$5.20

People also own

Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.